Morgan Stanley’s Urovant Sciences Ltd. UROV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-15,550
Closed -$251K 7653
2020
Q4
$251K Buy
+15,550
New +$251K ﹤0.01% 5478
2020
Q2
Sell
-1,000
Closed -$9K 6824
2020
Q1
$9K Buy
+1,000
New +$9K ﹤0.01% 6058
2019
Q1
Sell
-63
Closed 6787
2018
Q4
$0 Buy
+63
New ﹤0.01% 6817